To view this email as a web page, click here.

Timelines Matter in the Treatment of Breast Cancer

Researchers looked at the time between receiving a diagnosis and beginning chemotherapy to see if a delay in treatment impacted the overall survival in patients with breast cancer.

Racial Diversity Lacking in Oncology Clinical Trials

Many trials in the last decade that have led to FDA drug approvals didn't report on race and the ones that did were lacking in racial diversity.

IN CASE YOU MISSED IT

Should Patients with DLBCL and Concurrent FL be Included in Clinical Trials?

Researchers from the Mayo Clinic in Rochester, Minn. examined the disease histology and outcomes of patients with diffuse large B-cell lymphoma and a concurrent lymphoma.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.